Showing results (351-360 of 417) with videos related to

Sort By:
Pageof 42
Nature Communications|September 27, 2022
Predicting the evolution of the Lassa virus endemic area and population at risk over the next decadesRaphaëlle Klitting, Liana E Kafetzopoulou, Wim Thiery, et al.
NPJ Digital Medicine|July 18, 2025
Unlocking efficiency in real-world collaborative studies: a multi-site international study with one-shot lossless GLMM algorithmJiayi Tong, Jenna M Reps, Chongliang Luo, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
The emergence and molecular evolution of H5N1 influenza viruses in United States dairy cattleJonathan E Pekar, Karthik Gangavarapu, Alvin Crespo-Bellido, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort studyAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Drug Safety|June 2, 2022
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort StudyAzza Shoaibi, Gowtham A Rao, Erica A Voss, et al.
Plos Pathogens|December 7, 2019
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East AfricaNuno R Faria, Nicole Vidal, José Lourenco, et al.
Frontiers in Pharmacology|October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patientsAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Nature Communications|August 15, 2022
Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictionsEdyth Parker, Catelyn Anderson, Mark Zeller, et al.
Eclinicalmedicine|February 20, 2025
Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort studyJack L Janetzki, Jung Ho Kim, Evan Minty, et al.
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
Pageof 42